Is metformin safe in pregnancy, and before trying to conceive?
Reviewed 18 sourcesPublished by PepVault
Metformin in pregnancy and before conceiving: the label's lines, the MiG, PregMet and MiTy trial numbers, how the children grew, and how GLP-1 labels differ.

- Last reviewed
- Sources
- 18
- Questions
- 8
- Compounds
- 3
The short answer
The metformin label says data in pregnant women are too limited to set a risk for birth defects or miscarriage, and published studies show no clear link. Randomised trials in gestational diabetes, PCOS and type 2 diabetes found no rise in newborn complications; some found heavier children years later. Most of a dose clears within a day, and it can restart ovulation. Whether to continue is your prescriber's call.
Evidence: The FDA labels for metformin and four GLP-1 brands (DailyMed), four randomised trials of metformin in pregnancy and their child follow-ups, one randomised fertility trial, a national register study and the 2023 international PCOS guideline; no trial was large enough to rule out rare harms, and the long-term effects on children are still being followed.

What does the metformin label say about pregnancy?
Metformin is approved in the US for one thing: blood sugar control in type 2 diabetes, in adults and in children from 10 years old1. Its use for gestational diabetes (diabetes that first appears in pregnancy) or for PCOS (polycystic ovary syndrome, a hormone condition that often stops ovulation) is off-label, meaning a prescriber uses it outside the approved indication. The label's pregnancy and fertility lines are short, and they carry most of the answer1:
- Pregnancy (8.1): "Limited data with metformin … in pregnant women are not sufficient to determine a drug-associated risk for major birth defects or miscarriage. Published studies with metformin use during pregnancy have not reported a clear association with metformin and major birth defect or miscarriage risk." The label adds that those studies were small and used uneven comparison groups, so they "cannot definitely establish the absence of any metformin-associated risk"1.
- The disease itself (8.1): poorly controlled diabetes in pregnancy raises the mother's risk of pre-eclampsia, miscarriage, preterm delivery and stillbirth, and the baby's risk of birth defects. The label puts the background rate of major birth defects at 6 to 10% in diabetes from before pregnancy with an HbA1c above 7, and up to 20 to 25% above 10, against 2 to 4% in the general population1.
- Animals (8.1): in rats and rabbits given up to about 2 and 5 times the top human dose, development was not affected, and the placenta was a partial barrier1.
- Fertility (8.3): "Discuss the potential for unintended pregnancy with premenopausal women as therapy with metformin … may result in ovulation in some anovulatory women"1.
That last line matters before anyone is trying: in women whose cycles have stopped, often with PCOS, a pregnancy can come sooner than expected1.

How does metformin compare with Ozempic, Wegovy, Mounjaro and Zepbound before a planned pregnancy?
Many people take metformin beside a GLP-1 or switch between them, and the labels treat a planned pregnancy differently. The gap comes from the half-life, the time it takes for half the drug to leave the blood. Metformin's plasma half-life is about 6.2 hours, and about 90% of the absorbed drug is cleared by the kidneys within 24 hours1. Semaglutide's is about a week23.
| Label | Half-life | Before a planned pregnancy | Fertility or the pill | Once pregnant |
|---|---|---|---|---|
| Metformin1 | About 6.2 hours (about 17.6 hours in whole blood) | No stop interval given | May bring back ovulation; discuss unintended pregnancy | No clear link to birth defects in published studies; the risks of uncontrolled diabetes are named |
| Ozempic (semaglutide)2 | About 1 week | Stop at least 2 months before, "due to the long washout period" | No contraception step | Use only if the benefit justifies the risk to the fetus |
| Wegovy (semaglutide)3 | About 1 week | Stop at least 2 months before, "to account for the long half-life" | No contraception step | Stop when used for weight or heart risk (for MASH, benefit against risk); a pregnancy registry exists |
| Mounjaro and Zepbound (tirzepatide)45 | About 5 days | No stop interval given | Switch from the pill to a non-oral method, or add a barrier, for 4 weeks after starting and after each dose increase | Mounjaro: benefit against risk; Zepbound: stop when pregnancy is recognised |
So metformin has no wash-out problem: it is gone from the blood within a few days of the last tablet, and its label sets no stop date.
PepVault logs every tablet and shot with its date, so the day of your last dose of each medicine is on record when your prescriber or obstetrician asks. Log it in PepVault
Does metformin help you get pregnant with PCOS?
It helps some women ovulate, but other drugs work better for a baby. In the largest trial, 626 women with PCOS and infertility took metformin, clomiphene (an ovulation drug) or both for up to 6 months. Live births were 7.2% on metformin, 22.5% on clomiphene and 26.8% on the two together6. Among women who did ovulate, conception was lower on metformin: 21.7% against 39.5% on clomiphene6.
The 2023 international PCOS guideline follows that evidence. Letrozole, another ovulation drug, is its first choice; metformin "could be used alone" to improve pregnancy and live birth rates, "whilst informing women that there are more effective ovulation agents"7. Where metformin is added during IVF, the guideline suggests stopping it at the pregnancy test or period unless there is another reason to take it, such as diabetes7. How a GLP-1 compares for PCOS is in our guide to GLP-1s and PCOS.
Commonly reported: periods returning within a few months of starting metformin, surprise pregnancies in women told they would struggle to conceive, and loose stools in the first weeks that settle as the dose climbs.
What did the trials of metformin in pregnancy find?
Four randomised trials give the best evidence. None found more newborn complications overall on metformin, and none was large enough to rule out rare effects:
| Trial | Who | Compared | Main result |
|---|---|---|---|
| MiG, 20088 | 751 women with gestational diabetes | Metformin (insulin added if needed) vs insulin | Newborn complications 32.0% vs 32.2%; 46.3% on metformin also needed insulin; 76.6% vs 27.2% would choose their treatment again |
| PregMet, 20109 | 257 women with PCOS, from the first trimester | Metformin vs placebo | Pre-eclampsia, gestational diabetes or preterm birth 25.9% vs 24.4%, no difference; less weight gained on metformin |
| PregMet2, 201910 | 487 women with PCOS | Metformin vs placebo | Late miscarriage or preterm birth 5% vs 10% (not significant alone); gestational diabetes 25% vs 24%; pooled with earlier trials, 5% vs 10%, significant |
| MiTy, 202011 | 502 women with type 2 diabetes on insulin | Metformin added vs placebo added | Newborn complications 40% vs 40%; less weight gained (7.2 vs 9.0 kg), fewer caesareans (53% vs 63%), fewer babies of 4 kg or more (12% vs 19%), more small babies (13% vs 7%) |
The pattern runs through all four. Metformin did as well as insulin in gestational diabetes and helped with weight gain and big babies, but it did not prevent gestational diabetes in PCOS, and in type 2 diabetes about twice as many babies were small for their age891011. Finland's register study found the same rise in small babies against insulin, and its authors advise caution where a baby is already at risk of growing too little17.
Does metformin in pregnancy affect the child later on?
Metformin crosses the placenta, so the trials followed the children. The results are mixed, and this is the part that is still open:
| Follow-up | Children | Finding |
|---|---|---|
| MiG TOFU, age 212 | 318 | More fat under the skin on arm measures, but the same total body fat |
| MiG TOFU, ages 7 to 913 | 208 | At 9 (Auckland), metformin children were larger by weight and waist; body fat percentage, liver fat and blood tests were the same |
| PregMet trials, age 414 | 182 | Overweight or obesity in 32% vs 18% on placebo |
| PedMet, ages 5 to 1015 | 141 | Higher BMI score (a difference of 0.41), the authors' own worry for heart health later |
| MiTy Kids, age 216 | 283 | No difference in BMI score or skinfolds |
| CLUE, Finland's registers17 | 3,967 on metformin vs 5,273 on insulin | No rise in childhood obesity, diabetes or developmental problems; more small babies at birth (odds ratio 1.65) |
The heavier-child signal appears mostly in the PCOS trials and at 9 years in one MiG group. It did not show overall in the type 2 diabetes trial, though boys' BMI ran higher between 6 and 24 months, or in Finland's national records, a study sponsored by Merck KGaA, the metformin originator14151617. The PCOS guideline's advice to clinicians is to tell women that long-term effects on the child "remain unclear and there is a suggestion of increased childhood weight, although causality is not certain"7.
Do you keep taking metformin once you are pregnant?
It depends on why you take it, and the decision belongs to your prescriber and obstetrician. In type 2 diabetes, the label's own warning is about the disease: high blood sugar early in pregnancy is what raises the risk of birth defects1. The UK regulator updated metformin's product information in 2022 to allow its use in pregnancy and around conception "as an addition or an alternative to insulin, if clinically needed", after the Finnish register study found no safety signal of concern18.
In PCOS without diabetes, the 2023 guideline does not recommend metformin routinely in pregnancy, since it did not prevent gestational diabetes, pre-eclampsia or big babies; it could be considered in some cases, such as a high risk of preterm birth, to reduce preterm delivery and limit excess weight gain7. Its side effects are "mostly mild, transient gastrointestinal symptoms and are not worse in pregnancy"7.
PepVault's bloodwork log keeps HbA1c and fasting glucose side by side over time, so the numbers from before you started trying sit next to the ones from your first antenatal visit. Log it in PepVault
When to get help A positive pregnancy test while on metformin is a reason to call your prescriber or obstetrician within days, and anyone taking it for diabetes should not stop without that conversation.
Can you take metformin while breastfeeding?
Metformin passes into milk in small amounts: in published studies, the baby's dose was about 0.11% to 1% of the mother's weight-adjusted dose1. The label says there is too little information on effects on the baby or on milk supply, so the benefits of breastfeeding are weighed against the mother's need for the drug, a decision for her and her prescriber1.
What should you ask your prescriber before trying to conceive?
- Do I take metformin for diabetes, for PCOS or for weight, and does that change once I am pregnant?
- If my periods come back on metformin, what contraception do I use until we are ready?
- If I also take a GLP-1, when should my last dose be, and what replaces it?
- What should my HbA1c be before I try?
- If I stay on metformin, will my baby's growth be checked on scans?
For what the GLP-1 labels and studies say about the same months, read our guide to GLP-1s and pregnancy next.
Sources
- Laurus Labs. Metformin hydrochloride tablets and extended-release tablets, prescribing information (DailyMed, SPL version 8, Sep 28, 2026): sections 1, 8.1, 8.2, 8.3, 12.3 and 17. dailymed.nlm.nih.gov
- Novo Nordisk. OZEMPIC (semaglutide) injection, prescribing information (DailyMed, SPL version 20, Jun 2026): sections 8.1, 8.3 and 12.3. dailymed.nlm.nih.gov
- Novo Nordisk. WEGOVY (semaglutide) injection and tablets, prescribing information (DailyMed, SPL version 19, 2026): sections 8.1, 8.3 and 12.3. dailymed.nlm.nih.gov
- Eli Lilly and Company. MOUNJARO (tirzepatide) injection, prescribing information (DailyMed, SPL version 40, Aug 2026): sections 8.1, 8.3 and 12.3. dailymed.nlm.nih.gov
- Eli Lilly and Company. ZEPBOUND (tirzepatide) injection, prescribing information (DailyMed, SPL version 40, Aug 2026): sections 8.1, 8.3 and 12.3. dailymed.nlm.nih.gov
- Legro RS, Barnhart HX, Schlaff WD, et al. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med. 2007;356(6):551-566. PubMed 17287476
- Teede HJ, Tay CT, Laven J, et al. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Hum Reprod. 2023;38(9):1655-1679. PubMed 37580037
- Rowan JA, Hague WM, Gao W, et al. Metformin versus insulin for the treatment of gestational diabetes (MiG). N Engl J Med. 2008;358(19):2003-2015. PubMed 18463376
- Vanky E, Stridsklev S, Heimstad R, et al. Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study (PregMet). J Clin Endocrinol Metab. 2010;95(12):E448-E455. PubMed 20926533
- Løvvik TS, Carlsen SM, Salvesen Ø, et al. Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 2019;7(4):256-266. PubMed 30792154
- Feig DS, Donovan LE, Zinman B, et al. Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial. Lancet Diabetes Endocrinol. 2020;8(10):834-844. PubMed 32946820
- Rowan JA, Rush EC, Obolonkin V, et al. Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition at 2 years of age. Diabetes Care. 2011;34(10):2279-2284. PubMed 21949222
- Rowan JA, Rush EC, Plank LD, et al. Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7-9 years of age. BMJ Open Diabetes Res Care. 2018;6(1):e000456. PubMed 29682291
- Hanem LGE, Stridsklev S, Júlíusson PB, et al. Metformin use in PCOS pregnancies increases the risk of offspring overweight at 4 years of age: follow-up of two RCTs. J Clin Endocrinol Metab. 2018;103(4):1612-1621. PubMed 29490031
- Hanem LGE, Salvesen Ø, Juliusson PB, et al. Intrauterine metformin exposure and offspring cardiometabolic risk factors (PedMet study): a 5-10 year follow-up of the PregMet randomised controlled trial. Lancet Child Adolesc Health. 2019;3(3):166-174. PubMed 30704873
- Feig DS, Sanchez JJ, Murphy KE, et al. Outcomes in children of women with type 2 diabetes exposed to metformin versus placebo during pregnancy (MiTy Kids): a 24-month follow-up of the MiTy randomised controlled trial. Lancet Diabetes Endocrinol. 2023;11(3):191-202. PubMed 36746160
- Brand KMG, Saarelainen L, Sonajalg J, et al. Metformin in pregnancy and risk of adverse long-term outcomes: a register-based cohort study (CLUE). BMJ Open Diabetes Res Care. 2022;10(1):e002363. PubMed 34987051
- Medicines and Healthcare products Regulatory Agency. Metformin in pregnancy: study shows no safety concerns. Drug Safety Update, volume 15, issue 8, March 15, 2022. gov.uk
Newsletter · Weekly
The weekly peptide briefing.
New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.